These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 16807617

  • 21. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
    Rake EC, Breeze E, Fletcher AE.
    J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
    [Abstract] [Full Text] [Related]

  • 22. Blood pressure reduction with olmesartan in mild-to-moderate essential hypertension: a planned interim analysis of an open label sub-study in German patients.
    Böhm M, Ewald S, Olmebest Study Authors.
    Curr Med Res Opin; 2006 Jul; 22(7):1375-80. PubMed ID: 16834836
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
    Sega R.
    Blood Press; 1999 Jul; 8(2):114-21. PubMed ID: 10451039
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J, Hirayama H, Hanasawa T, Watabe D, Asayama K, Metoki H, Kikuya M, Ohkubo T, Totsune K, Imai Y.
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [Abstract] [Full Text] [Related]

  • 25. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
    Hedner T, Himmelmann A.
    J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension.
    Smolensky MH, Hermida RC, Portaluppi F.
    Chronobiol Int; 2007 Jan; 24(1):171-81. PubMed ID: 17364587
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy and tolerability of the captopril and hydrochlorothiazide combination in the treatment of mild to moderate hypertension. Multicenter study].
    Velasco-Cornejo IF, Martin LC, Franco RJ.
    Arq Bras Cardiol; 1995 Jun; 64(6):571-5. PubMed ID: 8561680
    [Abstract] [Full Text] [Related]

  • 28. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
    Manyemba J.
    Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
    [Abstract] [Full Text] [Related]

  • 29. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK, Fischer HM, Pittrow D, Bohlscheid V.
    Fortschr Med Orig; 2003 Dec; 121(1):27-32. PubMed ID: 15117066
    [Abstract] [Full Text] [Related]

  • 30. Comparison of monotherapy versus combination antihypertensive therapy in elderly patients with essential hypertension.
    Antonopoulos S, Kokkoris S, Gerakari S, Mikros S, Nitsotolis T, Vikeli D, Korantzopoulos P, Giannoulis G.
    Angiology; 2008 Dec; 59(2):230-5. PubMed ID: 18388088
    [Abstract] [Full Text] [Related]

  • 31. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [Abstract] [Full Text] [Related]

  • 32. Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
    Pathak A, Hanon O, Negre-Pages L, Sevenier F, OSCAR investigators.
    Fundam Clin Pharmacol; 2007 Apr; 21(2):199-205. PubMed ID: 17391293
    [Abstract] [Full Text] [Related]

  • 33. Losartan with hydrochlorothiazide in the treatment of hypertension.
    Schoenberger JA, Losartan Research Group.
    J Hypertens Suppl; 1995 Jul; 13(1):S43-7. PubMed ID: 18800455
    [Abstract] [Full Text] [Related]

  • 34. Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension.
    Saruta T, Ogihara T, Matsuoka H, Suzuki H, Toki M, Hirayama Y, Nonaka K, Takahashi K.
    Hypertens Res; 2007 Aug; 30(8):729-39. PubMed ID: 17917321
    [Abstract] [Full Text] [Related]

  • 35. Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.
    Voors AA, van de Wal RM, Hartog JW, Vijn RG, Hummel YM, Plokker TW, van Veldhuisen DJ, Jaarsma W.
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):33-40. PubMed ID: 20229056
    [Abstract] [Full Text] [Related]

  • 36. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 37. Home blood pressure monitoring in blood pressure control among haemodialysis patients: an open randomized clinical trial.
    da Silva GV, de Barros S, Abensur H, Ortega KC, Mion D, Cochrane Renal Group Prospective Trial Register: CRG060800146.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3805-11. PubMed ID: 19586971
    [Abstract] [Full Text] [Related]

  • 38. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS.
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [Abstract] [Full Text] [Related]

  • 40. Angiotensin blockade with eprosartan: vascular and functional implications.
    Ram CV.
    Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S5-11. PubMed ID: 18093408
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.